Showing 2 posts of 2 posts found.
The US Food and Drug Administration has shown Roche’s eye-condition drug Lucentis the green light to treat patients with diabetic …
A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection
Coriolis Pharma appoints Teun van der Heide as CEO
NEC joins €6.5m European project using AI for pandemic vaccine design
The evidence bar impacting UK medical cannabis access